Month: March 2017

• March 28, 2017
• Imaging & mpMRI

British Study Confirms the Role of mpMRI Before Biopsy

Terrific news and a great way to start off 2017! On January 17, the prestigious medical journal The Lancet issued online publication of a British study, “Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study” (Ahmed et al., 2017[i]). This large trial validated the importance of multiparametric keep reading

• March 22, 2017
• General Prostate
• General Prostate Information

Is the Sky Falling? Worrisome Trends in Prostate Cancer Diagnosis and Treatment Patterns

Did you ever hear the folktale about Chicken Little, who was hit on the head by a falling acorn? He wanted to warn the king – and everyone else – that “the sky is falling!” The story and its many age-old variants satirizes people who are unduly alarmed and spread exaggerated rumors. However, three recent keep reading

• March 20, 2017
• General Prostate
• General Prostate Information

New Study Finds No Link between Hormone Therapy and Dementia

Androgen deprivation therapy (ADT, also called hormone therapy) is a strategy of biochemically controlling prostate cancer (PCa) by depriving it of testosterone. It is used in cases where Radiation or ablation is planned and the doctor needs to “shrink” the prostate gland to increase the effectiveness of the treatment PCa had already escaped the gland keep reading